SEC 13F Intelligence

Algert Global LLC / GMED

Algert Global LLC’s Globus Med Inc Position

Does Algert Global LLC own Globus Med Inc (GMED)? Yes126.9K shares worth $11M (+0.16% of its 13F portfolio) as of Q1 2026, up from 58.6K shares the prior filed quarter.

Position Value
$11M
Q1 2026
Shares
126.9K
% of Portfolio
+0.16%
Quarters Held
17
currently held

Position History GMED

Reported value by quarter
Q3 ’19: $302,000Q3 ’19Q4 ’19: $2MQ1 ’20: $2MQ2 ’20: $249,000Q2 ’20Q3 ’21: $211,000Q1 ’22: $3MQ1 ’23: $1MQ1 ’23Q2 ’23: $3MQ3 ’23: $2MQ4 ’23: $6MQ4 ’23Q1 ’24: $6MQ2 ’24: $5MQ3 ’24: $9MQ3 ’24Q4 ’24: $17MQ1 ’25: $11MQ4 ’25: $5MQ4 ’25Q1 ’26: $11Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026126.9K$11M+0.16%
Q4 202558.6K$5M+0.08%
Q1 2025154.7K$11M+0.28%
Q4 2024209.5K$17M+0.41%
Q3 2024121.2K$9M+0.23%
Q2 202478.4K$5M+0.18%
Q1 2024114.4K$6M+0.24%
Q4 2023115.3K$6M+0.25%
Q3 202332.9K$2M+0.08%
Q2 202351.7K$3M+0.13%
Q1 202323.2K$1M+0.06%
Q1 202239.7K$3M+0.19%
Q3 20212.8K$211,000+0.03%
Q2 20205.2K$249,000+0.08%
Q1 202035.6K$2M+0.64%
Q4 201932.8K$2M+0.58%
Q3 20195.9K$302,000+0.11%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Algert Global LLC’s full portfolio or all institutional holders of GMED.